If you are experiencing symptoms of COVID-19, you may be eligible for Blaze-1, an investigational treatment study. Participants in Blaze-1 will receive a free COVID-19 test and results within approximately 30 minutes.
In such uncertain times, your selflessness and willingness to participate in this vital trial is absolutely essential. Together, we will help stop the spread of COVID-19.
Enrolling August-September 2020
Respiratory Syncytial Virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults.
Moderna is taking a similar approach to a vaccine for RSV as they took for their historic and ground-breaking COVID-19 Vaccine. This experimental vaccine will use synthetic mRNA that contains the signature spike protein of RSV. The intent is that the mRNA will help instruct the body to produce proteins to prevent or fight RSV.
If you are experiencing Covid-19 symptoms, you may be eligible to participate in a clinical research study that measures the efficacy of an antigen test compared to a PCR test.
We are seeking individuals in South Carolina at risk for contracting COVID-19 to test a Covid Vaccine’s safety and ability to prevent the virus.
Moderna Phase 3 Trial
Johnson and Johnson Phase 3 Trial
Merck Phase 3 Trial